2-naphthol has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Backer, M; de Jongh, S; Jiskoot, W; Kapoerchan, VV; Metaxas, A; Nabuurs, RJ; Overhand, M; Overkleeft, HS; van Buchem, MA; van der Weerd, L; Welling, MM; Windhorst, AD | 1 |
| Bhattacharya, A; Cerchia, C; Lavecchia, A; Limone, A; Minopoli, G; Montuori, N; Napolitano, F; Parisi, S; Sarnataro, D | 1 |
| Damodaran, N; Deepak, KV; Dilna, A; Kagedal, K; Kielkopf, CS; Nath, S; Ollinger, K | 1 |
| Arya, A; Banala, VT; Mishra, PR; Mishra, S; Mitra, K; Mittapelly, N; Pandey, G; Sharma, S; Shukla, S; Thalla, M | 1 |
| Abrahim, A; Auff, E; Bauer, M; Brunner, M; Carminati, P; Corrado, ME; Dal-Bianco, P; Dudczak, R; Forloni, G; Ghirardi, O; Hofmann, A; Joukhadar, C; Karch, R; Kletter, K; Langer, O; Lanzenberger, R; Lods, N; Müller, M; Piovesan, P | 1 |
1 trial(s) available for 2-naphthol and Alzheimer Disease
| Article | Year |
|---|---|
A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Amyloid; Area Under Curve; Biological Availability; Blood-Brain Barrier; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Male; Molecular Structure; Naphthols; Neuroprotective Agents; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
4 other study(ies) available for 2-naphthol and Alzheimer Disease
| Article | Year |
|---|---|
Polyfluorinated bis-styrylbenzenes as amyloid-β plaque binding ligands.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene; Binding, Competitive; Brain; Contrast Media; Drug Design; Fluorescent Dyes; Fluorine; Humans; Ligands; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Protein Binding; Spectrometry, Fluorescence | 2014 |
APP Maturation and Intracellular Localization Are Controlled by a Specific Inhibitor of 37/67 kDa Laminin-1 Receptor in Neuronal Cells.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; Endoplasmic Reticulum; Endosomes; Glycosylation; Golgi Apparatus; HeLa Cells; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Laminin; Mice; Microscopy, Fluorescence; Naphthols; Neurons; Prion Proteins; Protein Processing, Post-Translational; Protein Transport; Receptors, Laminin; Ribosomal Proteins; RNA, Small Interfering; Signal Transduction | 2020 |
Amyloid-β induced membrane damage instigates tunneling nanotube-like conduits by p21-activated kinase dependent actin remodulation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cell Membrane; Disulfides; Endocytosis; Exocytosis; Humans; Lysosomes; Nanotubes; Naphthols; p21-Activated Kinases | 2021 |
Long Acting Ionically Paired Embonate Based Nanocrystals of Donepezil for the Treatment of Alzheimer's Disease: a Proof of Concept Study.
Topics: 3T3 Cells; Acetylcholinesterase; Alzheimer Disease; Animals; Cell Survival; Chemistry, Pharmaceutical; Donepezil; Drug Liberation; Female; Humans; Hydrophobic and Hydrophilic Interactions; Indans; Mice; Nanoparticles; Naphthols; Particle Size; Piperidines; Polyethylene Glycols; Proof of Concept Study; Rats, Sprague-Dawley; Solubility; Streptozocin; Surface Properties | 2017 |